Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells

Journal of Neuroscience Research

Volumn 91, Issue 1, 2013, Pages 116-127

  Darbinyan, Armine ^a   Kaminski, Rafal ^a   White, Martyn K ^a   Darbinian Sarkissian, Nune ^a   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Neural progenitor; Polyomavirus; Progressive multifocal leukoencephalopathy

Indexed keywords

CCL1 CHEMOKINE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; EOTAXIN 3; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; LYMPHOTACTIN; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; MYELIN BASIC PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEOLIPID PROTEIN; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ARTICLE; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; JC VIRUS; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NEURAL STEM CELL; NEUROPATHOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS PATHOGENESIS;

CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; NEURAL STEM CELLS; OLIGODENDROGLIA; POLYOMAVIRUS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS;

EID: 84869159038     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23135     Document Type: Article

References (57)

1. Alvarez-Buylla A, Kohwi M, Nguyen TM, Merkle FT. 2008. The heterogeneity of adult neural stem cells and the emerging complexity of their niche. Cold Spring Harbor Symp Quant Biol 73: 357-365.
2. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. 2003. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 23: 9824-9832.
3. Bajetto A, Bonavia R, Barbero S, Schettini G. 2002. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 82: 1311-1329.
4. Bartosik-Psujek H, Stelmasiak Z. 2005. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease. Eur J Neurol 12: 49-54.
5. Berger JR. 2010. Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf 33: 969-983.
6. Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H. 2010. Demyelination vs. remyelination in progressive multiple sclerosis. Brain 133: 2983-2998.
7. Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL. 2009. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10: 816-824.
8. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. 2005. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48: 16-42.
9. Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A. 2010. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9: 438-446.
10. Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL. 2011. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68: 1156-1164.
11. Darbinyan A, White MK, Akan S, Radhakrishnan S, Del Valle L, Amini S, Khalili K. 2007. Alterations of DNA damage repair pathways resulting from JCV infection. Virology 364: 73-86.
12. Del Valle L, Piña-Oviedo S. 2006. HIV disorders of the brain: pathology and pathogenesis. Front Biosci 11: 718-732.
13. Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. 1999. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97: 703-716.
14. Dupree JL, Mason JL, Marcus JR, Stull M, Levinson R, Matsushima GK, Popko B. 2004. Oligodendrocytes assist in the maintenance of sodium channel clusters independent of the myelin sheath. Neuron Glia Biol 1: 179-192.
15. Espinosa-Jeffrey A, Wakeman DR, Kim SU, Snyder EY, de Vellis J. 2009. Culture system for rodent and human oligodendrocyte specification, lineage progression, and maturation. Curr Protoc Stem Cell Biol Chapter 2, Unit 2D.4.
16. Garcia ADR, Doan NB, Imura T, Bush TG, Sofroniew MV. 2004. GFAP-expressing progenitors are the principle source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci 7: 1233-1241.
17. + T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85: 7256-7263.
18. Imura T, Kornblum HI, Sofroniew MV. 2003. The predominant neural stem cell isolated from postnatal and adult forebrain but not from early embryonic forebrain expresses GFAP. J Neurosci 23: 2824-2832.
19. Kadi L, Selvaraju R, de Lys P, Proudfoot AE, Wells TN, Boschert U. 2006. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J Neuroimmunol 174: 133-146.
20. Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH. 2009. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp Neurol 220: 44-56.
21. Khalili K, Gordon J, White MK. 2006. The polyomavirus, JCV and its involvement in human disease. Adv Exp Med Biol 577: 274-287.
22. Lassman H. 1983. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Berlin: Springer-Verlag.
23. Laywell ED, Rakic P, Kukekov VG, Holland EC, Steindler DA. 2000. Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A 97: 13883-13888.
24. Liu L, Belkadi A, Darnall L, Hu T, Drescher C, Cotleur AC, Padovani-Claudio D, He T, Choi K, Lane TE, Miller RH, Ransohoff RM. 2010a. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci 13: 319-326.
25. Liu L, Darnall L, Hu T, Choi K, Lane TE, Ransohoff RM. 2010b. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci 30: 9074-9083.
26. Major EO. 2010. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 61: 35-47.
27. Manley K, Gee GV, Simkevich CP, Sedivy JM, Atwood WJ. 2007. Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression. Virology 366: 394-404.
28. Marzocchetti A, Cingolani A, Giambenedetto SD, Ammassari A, Giancola ML, Cauda R, Antinori A, Luca AD. 2005. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. J Neurovirol 11: 219-224.
29. Mateen FJ, Muralidharan R, Carone M, van de Beek D, Harrison DM, Aksamit AJ, Gould MS, Clifford DB, Nath A. 2011. Progressive multifocal leukoencephalopathy in transplant recipients. Ann Neurol 70: 305-322.
30. Mázló M, Ressetar HG, Stoner GL. 2001. The neuropathology and pathogenesis of progressive multifocal leukoencephalopathy. In: Khalili K, Stoner GL, editors. Human polyomaviruses: molecular and clinical perspectives. New York: Wiley-Liss. p 257-335.
31. Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A. 2006. Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 26: 7907-7918.
32. Merabova N, Kaniowska D, Kaminski R, Deshmane SL, White MK, Amini S, Darbinyan A, Khalili K. 2008. JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis. J Virol 82: 1558-1569.
33. Merabova N, Kaminski R, Krynska B, Amini S, Khalili K, Darbinyan A. 2012. JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons. J Cell Physiol 227: 3119-3127.
34. Messam CA, Hou J, Gronostajski RM, Major EO. 2003. Lineage pathway of human brain progenitor cells identified by JC virus susceptibility. Ann Neurol 53: 636-646.
35. Miller RJ, Rostene W, Apartis E, Banisadr G, Biber K, Milligan ED, White FA, Zhang J. 2008. Chemokine action in the nervous system. J Neurosci 28: 11792-11795.
36. Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS, Trapp BD, Ransohoff RM. 2008. Cortical demyelination in PML and MS: similarities and differences. Neurology 70: 336-343.
37. Nave KA. 2010. Myelination and the trophic support of long axons. Nat Rev Neurosci 11: 275-283.
38. Nave KA, Trapp BD. 2008. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31: 535-561.
39. Omari KM, John G, Lango R, Raine CS. 2005a. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53: 24-31.
40. Omari KM, John GR, Sealfon SC, Raine CS. 2005b. CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128: 1003-1015.
41. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Brück W, Lucchinetti C, Lassmann H. 2006. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129: 3165-3172.
42. Piaton G, Gould RM, Lubetzki C. 2010. Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair. J Neurochem 114: 1243-1260.
43. Radhakrishnan S, Otte J, Enam S, Del Valle L, Khalili K, Gordon J. 2003. JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol 77: 10638-10644.
44. Radhakrishnan S, Gordon J, Del Valle L, Cui J, Khalili K. 2004. Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection. J Virol 78: 7264-7269.
45. Raine CS, Wu E. 1993. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 52: 199-204.
46. Ransohoff RM, Trebst C. 2002. Chemokines and chemokine receptors in multiple sclerosis: a few answers and many more questions. In: Ransohoff RM, Suzuki K, Proudfoot A, Hickey WF, Harrison JK, editors. Universes in delicate balance chemokines and the nervous system. New York: Elsevier. p 317-332.
47. Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, Nave KA, Bansal R. 2005. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50: 86-90.
48. Robinson S, Franic LA. 2001. Chemokine GRO1 and the spatial and temporal regulation of oligodendrocyte precursor proliferation. Dev Neurosci 23: 338-345.
49. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18: 10457-10463.
50. Tan CS, Koralnik IJ. 2010. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 9: 425-437.
51. Tavazzi E, White MK, Khalili K. 2012. Molecular insights into polyomavirus JC and clinical updates on progressive multifocal leukoencephalopathy. Rev Med Virol 22: 18-32.
52. Tsai HH, Frost E, To V, Robinson S, Ffrench-Constant C, Geertman R, Ransohoff RM, Miller RH. 2002. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110: 373-383.
53. Waxman SG. 1996. Pathophysiology of demyelinated and remyelinated axons. In: Cook SD, editor. Handbook of multiple sclerosis. New York: Dekker. p 257-294.
54. White MK, Khalili K. 2011. Pathogenesis of progressive multifocal leukoencephalopathy revisited. J Infect Dis 203: 578-586.
55. Wollebo HS, Safak M, Del Valle L, Khalili K, White MK. 2011. Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol 233: 46-53.
56. Wu Q, Miller RH, Ransohoff RM, Robinson S, Bu J, Nishiyama A. 2000. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J Neurosci 20: 2609-2617.
57. Zhang SC, Ge B, Duncan ID. 1999. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Natl Acad Sci U S A 96: 4089-4094.